Skip to main content
logo
Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
190.90
-30.30 (-13.70%)
Jul 30, 2026, 4:08 PM HKT

Duality Biotherapeutics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
Market Capitalization
20,00326,664--
Market Cap Growth
-33.17%---
Enterprise Value
16,40822,676--
Last Close Price
221.20298.20--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
PS Ratio
9.7112.94--
PB Ratio
7.419.87--
P/TBV Ratio
7.429.89--
P/FCF Ratio
98.18130.88--
P/OCF Ratio
92.38123.14--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
7.9611.00--
EV/FCF Ratio
80.54111.30--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.060.060.000.00
Debt / EBITDA Ratio
---0.01
Debt / FCF Ratio
0.820.820.020.01
Net Debt / Equity Ratio
-1.33-1.330.691.01
Net Debt / EBITDA Ratio
7.147.147.63-1.53
Net Debt / FCF Ratio
-17.64-17.64-4.94-1.40
Asset Turnover
0.620.621.08-
Quick Ratio
3.523.520.480.50
Current Ratio
3.653.650.490.52
Return on Equity (ROE)
-1282.14%-1282.14%--
Return on Assets (ROA)
-9.61%-9.61%-6.51%-
Return on Capital Employed (ROCE)
-16.20%-16.20%10.50%-69.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-14.44%-10.83%--
FCF Yield
1.02%0.76%--
Buyback Yield / Dilution
-714.45%-714.45%--